Alzheimer’s Drug: Real-World Results In!

Big news for anyone following Alzheimer’s treatments: a new study found that lecanemab, the FDA-approved drug, caused serious side effects in just 1% of real-world patients. The best part? People with very mild symptoms saw the most benefit and the least risk. Turns out, with the right monitoring, this drug is safer than many feared. If you or someone you know is considering treatment, these results could be a game-changer! #Alzheimers #HealthNews #MedicalBreakthrough #Lecanemab #BrainHealth #Health